Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas.
Cellular delivery of a replication-conditional herpes simplex virus type 1 (HSV-1) vector provides a means for gene therapy of invasive tumor cells. LacZ-bearing neural precursor cells, which can migrate and differentiate in the brain, were infected with a ribonucleotide reductase-deficient HSV-1 mutant virus (rRp450) that replicates only in dividing cells. Replication of rRp450 in neural precursor cells was blocked prior to implantation into the tumor by growth arrest in late G1 phase through treatment with mimosine. Viral titers in the medium of mimosine-treated, rRp450-infected neural precursor cells were below detection levels 3 days after infection. In culture, after removal of mimosine and passaging, cells resumed growth and replication of rRp450 so that, 7 days later, virus was present in the medium and cell death was evident. Mimosine-treated neural precursor cells injected into established intracerebral CNS-1 gliomas in nude mice migrated extensively throughout the tumor and into the surrounding parenchyma beyond the tumor over 3 days. Mimosine-treated neural precursor cells, infected with rRp450 and injected into intracerebral CNS-1 tumors, also migrated within the tumor with the appearance of foci of HSV-thymidine kinase-positive (TK+) cells, presumably including tumor cells, distributed throughout the tumor and in the surrounding parenchyma over a similar period. This migratory cell delivery method has the potential to expand the range of delivery of HSV-1 vectors to tumor cells in the brain.
Neurology Service, Massachusetts General Hospital and Harvard Medical School, Charlestown 02129, USA.
U
U
Herrlinger
C
C
Woiciechowski
M
M
Sena-Esteves
K S
KS
Aboody
A H
AH
Jacobs
N G
NG
Rainov
E Y
EY
Snyder
X O
XO
Breakefield
D000818:Animals; D001932:Brain Neoplasms / Q000473:pathology / Q000628:therapy*; D002465:Cell Movement; D015774:Ganciclovir / Q000494:pharmacology; D005814:Genes, Viral; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors; D005910:Glioma / Q000473:pathology / Q000628:therapy*; D017405:Herpes Simplex Virus Protein Vmw65 / Q000235:genetics; D018259:Herpesvirus 1, Human / Q000235:genetics* / Q000502:physiology; D051379:Mice; D008819:Mice, Nude; D008898:Mimosine / Q000494:pharmacology; D009154:Mutation; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000821:virology*; D012264:Ribonucleotide Reductases / Q000235:genetics; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects / Q000821:virology*; D013937:Thymidine Kinase / Q000235:genetics; D014779:Virus Replication / Q000187:drug effects
D017405:Herpes Simplex Virus Protein Vmw65; D008898:Mimosine; D012264:Ribonucleotide Reductases; D013937:Thymidine Kinase; D015774:Ganciclovir